The global market for artificial intelligence in diagnostics is poised for significant growth, projected to reach USD 9.7 billion by 2033, driven by the increasing demand for rapid and precise disease detection.
The artificial intelligence (AI) diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 21.7% between 2026 and 2033, reflecting the surging adoption of AI-powered diagnostic tools. As healthcare systems worldwide seek to enhance early detection and accuracy, AI technologies are becoming integral in various fields, including medical imaging and pathology. The market was valued at USD 2.0 billion in 2025 and is anticipated to expand rapidly, with North America currently holding a significant share of 54.8% in revenue.
Chronic diseases such as cancer and cardiovascular conditions are driving the need for advanced diagnostic solutions. AI systems are increasingly utilized to automate image interpretation and improve clinical workflows, enabling healthcare providers to handle growing patient demands effectively. The software segment is leading market growth, accounting for 46.2% of revenue in 2025, as innovations in AI algorithms and cloud-based platforms enhance real-time data analysis.
Neurology is the leading diagnosis segment, attributed to the rising prevalence of neurological disorders where timely and accurate diagnosis is crucial. As AI applications expand, especially in oncology, the potential for improved patient outcomes through enhanced diagnostic capabilities becomes increasingly evident. The Asia Pacific region is also emerging as a key player, driven by increased healthcare digitization and the adoption of AI technologies in response to growing healthcare demands.
This projected growth in the AI diagnostics market underscores the transformative potential of technology in healthcare, paving the way for improved diagnostic accuracy and efficiency. As organizations continue to invest in AI innovations, the landscape of healthcare diagnostics is set to evolve significantly, addressing both workforce challenges and the need for timely medical interventions.